ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,052,000 | +53.1% | 32,837 | -1.9% | 0.02% | +36.4% |
Q3 2021 | $1,993,000 | -14.7% | 33,471 | -2.3% | 0.01% | +37.5% |
Q2 2021 | $2,337,000 | -0.6% | 34,266 | +1.1% | 0.01% | 0.0% |
Q1 2021 | $2,352,000 | -9.4% | 33,889 | +0.3% | 0.01% | -20.0% |
Q4 2020 | $2,597,000 | -0.1% | 33,799 | -2.8% | 0.01% | -16.7% |
Q3 2020 | $2,600,000 | +19.9% | 34,769 | +0.9% | 0.01% | +20.0% |
Q2 2020 | $2,168,000 | +72.6% | 34,443 | +15.2% | 0.01% | +42.9% |
Q1 2020 | $1,256,000 | -12.5% | 29,897 | -5.5% | 0.01% | +16.7% |
Q4 2019 | $1,436,000 | -0.6% | 31,625 | +0.2% | 0.01% | 0.0% |
Q3 2019 | $1,444,000 | -22.5% | 31,548 | -0.7% | 0.01% | -14.3% |
Q2 2019 | $1,863,000 | +31.3% | 31,769 | +0.4% | 0.01% | +40.0% |
Q1 2019 | $1,419,000 | +11.5% | 31,655 | -3.1% | 0.01% | 0.0% |
Q4 2018 | $1,273,000 | -16.0% | 32,683 | -0.8% | 0.01% | 0.0% |
Q3 2018 | $1,516,000 | +7.5% | 32,933 | +1.8% | 0.01% | 0.0% |
Q2 2018 | $1,410,000 | +16.3% | 32,340 | +5.4% | 0.01% | +25.0% |
Q1 2018 | $1,212,000 | +34.7% | 30,671 | +15.8% | 0.00% | +33.3% |
Q4 2017 | $900,000 | +35.3% | 26,487 | +1.6% | 0.00% | +50.0% |
Q3 2017 | $665,000 | +98.5% | 26,081 | +31.2% | 0.00% | +100.0% |
Q2 2017 | $335,000 | – | 19,873 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |